News for Valneva SE (INRLF)

U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Wednesday. Shares of GE Vernova Inc. GEV rose sharply during Wednesday's session...

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. Shares of MP Materials Corp. MP rose sharply during Tuesday's session af...

Summary: Valneva's chikungunya vaccine receives renewed EMA approval for seniors. Analysts forecast significant upside for Valneva SE (VALN) with a poten

Key Takeaways: Valneva SE partners with CSL Limited to boost vaccine distribution in Germany. Analysts predict a significant upside for Valneva SE stock.

Valneva (VALN) saw its stock price decline by 2% to $6.05 in early trading. The drop comes after the United Kingdom announced restrictions on the use of one of

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has decided to temporarily limit the administration of Valneva's (VALN) chikungunya vaccine,

**media[646307]**

Key Takeaways: U.S. health agencies advise pausing Valneva's chikungunya vaccine for ages 60+ due to safety concerns. Valneva SE (VALN) shows a potential ups

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what justifies INRLF stock a Buy.

**media[616890]**

**media[606597]**

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (”œValneva” or the ”œCompany”)

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Fi

PR NewswireNEW YORK, April 22, 2025 NEW YORK, April 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("

**media[598772]**

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (”œValneva” or the ”œCompany”)

PR NewswireNEW YORK, April 14, 2025 NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("V

NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (”œValneva” or the ”œCompany”)

**media[589792]**